PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
63.91%
Revenue growth above 1.5x AR's 35.73%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
467.26%
Gross profit growth above 1.5x AR's 52.33%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
62.90%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
62.90%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
65.30%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
65.32%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
65.32%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.00%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
321.37%
OCF growth above 1.5x AR's 51.66%. David Dodd would confirm a clear edge in underlying cash generation.
205.19%
FCF growth above 1.5x AR's 59.61%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-72.18%
Negative 10Y revenue/share CAGR while AR stands at 1052.34%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.29%
Negative 5Y CAGR while AR stands at 150.51%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
3.54%
3Y revenue/share CAGR under 50% of AR's 41.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-78.91%
Negative 10Y OCF/share CAGR while AR stands at 164.47%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-29.56%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
3.45%
Positive 3Y OCF/share CAGR while AR is negative. John Neff might see a big short-term edge in operational efficiency.
-242.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
20.35%
Positive 5Y CAGR while AR is negative. John Neff might view this as a strong mid-term relative advantage.
-487.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-85.78%
Negative equity/share CAGR over 10 years while AR stands at 226.67%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-58.07%
Negative 5Y equity/share growth while AR is at 1.24%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-53.19%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-90.75%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-59.12%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
28.42%
3Y dividend/share CAGR of 28.42% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-6.53%
Firm’s AR is declining while AR shows 36.85%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-9.75%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-25.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.85%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-16.70%
We cut SG&A while AR invests at 5.79%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.